"St. Anne Hospital is dedicated to delivering high quality, compassionate care to Burien and nearby communities. Visit us at 16251 Sylvester Rd SW or call (206) 244-9970 for more information."

During the past decade, Highline Medical Center-Main Campus conducted 137 clinical trials. In the 10-year time frame, 137 clinical trials started and 90 clinical trials were completed, i.e. on average, 65.7% percent of trials that started reached the finish line to date. In the past 5 years, 56 clinical trials started and 57 clinical trials were completed. i.e. 101.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Highline Medical Center-Main Campus" #1 sponsor was "National Cancer Institute (NCI)" with 101 trials, followed by "SWOG Cancer Research Network" with 51 trials sponsored, "Alliance for Clinical Trials in Oncology" with 26 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored and "NRG Oncology" with 17 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Highline Medical Center-Main Campus" #1 collaborator was "National Cancer Institute (NCI)" with 109 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Highline Medical Center-Main Campus" are "Breast Cancer" (12 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Recurrent Breast Carcinoma" (7 trials), "Recurrent Ovarian Carcinoma" (7 trials) and "Stage IV Lung Cancer AJCC v8" (7 trials). Many other conditions were trialed in "Highline Medical Center-Main Campus" in a lesser frequency.

Most popular intervention types in "Highline Medical Center-Main Campus" are "Drug" (170 trials), "Other" (123 trials), "Biological" (96 trials), "Procedure" (51 trials) and "Radiation" (26 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (61 trials), "Quality-of-Life Assessment" (43 trials), "Computed Tomography" (28 trials), "Nivolumab" (28 trials) and "Questionnaire Administration" (28 trials). Other intervention names were less common.

The vast majority of trials in "Highline Medical Center-Main Campus" are 172 trials for "All" genders, 33 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Highline Medical Center-Main Campus". undefined are not yet recruiting, 54 are recruiting, 97 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Highline Medical Center-Main Campus, 2 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Highline Medical Center-Main Campus, 6 "Phase 1" clinical trials were conducted, 110 "Phase 2" clinical trials and 97 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".